FdaApplication
ANDA 208494
Identifiers
- fda_app_no: ANDA208494
Properties
| Property | Value |
|---|---|
| applicant_name | REYOUNG CORPORATION |
| application_type | ANDA |
| approval_date | 2020-06-12 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 100MG BASE | TABLET;ORAL |
| SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 25MG BASE | TABLET;ORAL |
| SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 50MG BASE | TABLET;ORAL |
3 products